Displaying 10 out of 7 results

  1. FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital

    Mylan to launch generic remdesivir version in India at US$64 per 100 mg vial

    Drugmaker Mylan NV said on Monday it would launch its generic version of Gilead Sciences Inc's COVID-19 treatment remdesivir in India this month ...
  2. The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel

    US FDA approves generic versions of Novartis blockbuster MS treatment

    The U.S. Food and Drug Administration on Thursday approved three generic versions of Swiss drugmaker Novartis AG's top-selling multiple sclerosis ...
  3. The building of the new customers site is seen in Tourcoing

    US Supreme Court to consider blocking trademark

    The U.S. Supreme Court on Friday agreed to consider a bid by a federal agency to prevent the popular hotel reservation website, a unit ...
  4. Logo of Mylan Laboratories, a company primarily engaged in the commercialization of generic drugs i

    Mylan third-quarter profit rises 7per cent on new drug launches

    Mylan NV reported a 7.4per cent rise in third-quarter profit on Tuesday, as the generic drugmaker benefited from new product launches.
  5. FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv

    Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar

    Teva Pharmaceutical Industries Ltd's proposed US$23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company ...